Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Ohio's Proposed Ban On Sales Marks Kratom Industry's Latest Battlefront

Oct 05 2018

• By Malcolm Spicer

State Law_484086778 _1200.jpg

Related Content

DEA Proposal To Schedule Kratom Stirs Wave Of Opposition

Dec 08 2016

Opioid Withdrawal Treatment Claims Spur FDA's Latest Kratom Warnings

May 23 2018

FDA's Opioid Label For Kratom Called Misbranding By Marketers

Feb 07 2018

Additional Topics

United States US States Dietary Supplements Regulation FDA Advertising, Marketing & Sales Manufacturing Safety Consumer

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window